The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Measles-Global Market Insights and Sales Trends 2024
Synopsis
Measles is a highly contagious infectious disease caused by the measles virus. Symptoms usually develop 10–12 days after exposure to an infected person and last 7–10 days. Initial symptoms typically include fever, often greater than 40 °C (104.0 °F), cough, runny nose, and inflamed eyes. Small white spots known as Koplik's spots may form inside the mouth two or three days after the start of symptoms. A red, flat rash which usually starts on the face and then spreads to the rest of the body typically begins three to five days after the start of symptoms. Complications occur in about 30% of cases and may include diarrhea, blindness, inflammation of the brain, and pneumonia, among others.
The global Measles market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Measles in various end use industries. The expanding demands from the Hospitals, Clinics and Others,, are propelling Measles market. Antibiotic, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Antiviral segment is estimated at % CAGR for the next seven-year period.
There is no specific antiviral treatment if measles develops. Instead the medications are generally aimed at treating super infections, maintaining good hydration with adequate fluids, and pain relief. Some groups are also given vitamin A, like young children and the severely malnourished, which act as an immunomodulator that boosts the antibody responses to measles and decreases the risk of serious complications.
Report Objectives
This report provides market insight on the different segments, by players, by Treatment, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Measles, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Measles market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Measles market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Measles sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Measles covered in this report include Novartis, Abbott, Biomedical Diagnostics, Johnson & Johnson Services, Sanofi, Merck and Serum Institute Of India, etc.
The global Measles market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Novartis
Abbott
Biomedical Diagnostics
Johnson & Johnson Services
Sanofi
Merck
Serum Institute Of India
Global Measles market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Measles market, Segment by Treatment:
Antibiotic
Antiviral
Vaccine
Global Measles market, by Application
Hospitals
Clinics
Others
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Treatment, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Measles companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Measles is a highly contagious infectious disease caused by the measles virus. Symptoms usually develop 10–12 days after exposure to an infected person and last 7–10 days. Initial symptoms typically include fever, often greater than 40 °C (104.0 °F), cough, runny nose, and inflamed eyes. Small white spots known as Koplik's spots may form inside the mouth two or three days after the start of symptoms. A red, flat rash which usually starts on the face and then spreads to the rest of the body typically begins three to five days after the start of symptoms. Complications occur in about 30% of cases and may include diarrhea, blindness, inflammation of the brain, and pneumonia, among others.
The global Measles market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Measles in various end use industries. The expanding demands from the Hospitals, Clinics and Others,, are propelling Measles market. Antibiotic, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Antiviral segment is estimated at % CAGR for the next seven-year period.
There is no specific antiviral treatment if measles develops. Instead the medications are generally aimed at treating super infections, maintaining good hydration with adequate fluids, and pain relief. Some groups are also given vitamin A, like young children and the severely malnourished, which act as an immunomodulator that boosts the antibody responses to measles and decreases the risk of serious complications.
Report Objectives
This report provides market insight on the different segments, by players, by Treatment, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Measles, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Measles market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Measles market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Measles sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Measles covered in this report include Novartis, Abbott, Biomedical Diagnostics, Johnson & Johnson Services, Sanofi, Merck and Serum Institute Of India, etc.
The global Measles market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Novartis
Abbott
Biomedical Diagnostics
Johnson & Johnson Services
Sanofi
Merck
Serum Institute Of India
Global Measles market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Measles market, Segment by Treatment:
Antibiotic
Antiviral
Vaccine
Global Measles market, by Application
Hospitals
Clinics
Others
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Treatment, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Measles companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Measles
1.1 Measles Market Overview
1.1.1 Measles Product Scope
1.1.2 Measles Market Status and Outlook
1.2 Global Measles Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Measles Market Size by Region (2018-2029)
1.4 Global Measles Historic Market Size by Region (2018-2023)
1.5 Global Measles Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Measles Market Size (2018-2029)
1.6.1 North America Measles Market Size (2018-2029)
1.6.2 Europe Measles Market Size (2018-2029)
1.6.3 Asia-Pacific Measles Market Size (2018-2029)
1.6.4 Latin America Measles Market Size (2018-2029)
1.6.5 Middle East & Africa Measles Market Size (2018-2029)
2 Measles Market by Treatment
2.1 Introduction
2.1.1 Antibiotic
2.1.2 Antiviral
2.1.3 Vaccine
2.2 Global Measles Market Size by Treatment: 2018 VS 2022 VS 2029
2.2.1 Global Measles Historic Market Size by Treatment (2018-2023)
2.2.2 Global Measles Forecasted Market Size by Treatment (2024-2029)
2.3 Key Regions Market Size by Treatment
2.3.1 North America Measles Revenue Breakdown by Treatment (2018-2029)
2.3.2 Europe Measles Revenue Breakdown by Treatment (2018-2029)
2.3.3 Asia-Pacific Measles Revenue Breakdown by Treatment (2018-2029)
2.3.4 Latin America Measles Revenue Breakdown by Treatment (2018-2029)
2.3.5 Middle East and Africa Measles Revenue Breakdown by Treatment (2018-2029)
3 Measles Market Overview by Application
3.1 Introduction
3.1.1 Hospitals
3.1.2 Clinics
3.1.3 Others
3.2 Global Measles Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Measles Historic Market Size by Application (2018-2023)
3.2.2 Global Measles Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Measles Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Measles Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Measles Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Measles Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Measles Revenue Breakdown by Application (2018-2029)
4 Measles Competition Analysis by Players
4.1 Global Measles Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Measles as of 2022)
4.3 Date of Key Players Enter into Measles Market
4.4 Global Top Players Measles Headquarters and Area Served
4.5 Key Players Measles Product Solution and Service
4.6 Competitive Status
4.6.1 Measles Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Novartis
5.1.1 Novartis Profile
5.1.2 Novartis Main Business
5.1.3 Novartis Measles Products, Services and Solutions
5.1.4 Novartis Measles Revenue (US$ Million) & (2018-2023)
5.1.5 Novartis Recent Developments
5.2 Abbott
5.2.1 Abbott Profile
5.2.2 Abbott Main Business
5.2.3 Abbott Measles Products, Services and Solutions
5.2.4 Abbott Measles Revenue (US$ Million) & (2018-2023)
5.2.5 Abbott Recent Developments
5.3 Biomedical Diagnostics
5.3.1 Biomedical Diagnostics Profile
5.3.2 Biomedical Diagnostics Main Business
5.3.3 Biomedical Diagnostics Measles Products, Services and Solutions
5.3.4 Biomedical Diagnostics Measles Revenue (US$ Million) & (2018-2023)
5.3.5 Johnson & Johnson Services Recent Developments
5.4 Johnson & Johnson Services
5.4.1 Johnson & Johnson Services Profile
5.4.2 Johnson & Johnson Services Main Business
5.4.3 Johnson & Johnson Services Measles Products, Services and Solutions
5.4.4 Johnson & Johnson Services Measles Revenue (US$ Million) & (2018-2023)
5.4.5 Johnson & Johnson Services Recent Developments
5.5 Sanofi
5.5.1 Sanofi Profile
5.5.2 Sanofi Main Business
5.5.3 Sanofi Measles Products, Services and Solutions
5.5.4 Sanofi Measles Revenue (US$ Million) & (2018-2023)
5.5.5 Sanofi Recent Developments
5.6 Merck
5.6.1 Merck Profile
5.6.2 Merck Main Business
5.6.3 Merck Measles Products, Services and Solutions
5.6.4 Merck Measles Revenue (US$ Million) & (2018-2023)
5.6.5 Merck Recent Developments
5.7 Serum Institute Of India
5.7.1 Serum Institute Of India Profile
5.7.2 Serum Institute Of India Main Business
5.7.3 Serum Institute Of India Measles Products, Services and Solutions
5.7.4 Serum Institute Of India Measles Revenue (US$ Million) & (2018-2023)
5.7.5 Serum Institute Of India Recent Developments
6 North America
6.1 North America Measles Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Measles Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Measles Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Measles Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Measles Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Measles Market Dynamics
11.1 Measles Industry Trends
11.2 Measles Market Drivers
11.3 Measles Market Challenges
11.4 Measles Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
